cinacalcet has been researched along with Disease Exacerbation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Aschenbach, R; Biermann, A; Freesmeyer, M; Kloos, C; Lupp, A; Mtuka-Pardon, G; Seifert, P; Werner, C; Wolf, G | 1 |
| Hur, C; Kuo, JH; Lee, JA; McManus, C; Oh, A | 1 |
| Buck, A; Fassnacht, M; Fröhling, S; Fuss, CT; Germer, CT; Hübschmann, D; Kickuth, R; Kircher, S; Kroiss, M; Lenschow, C; Reibetanz, J; Schlegel, N; Stenzinger, A; Wiegering, A | 1 |
| Yokoyama, K | 1 |
| Inaba, M | 1 |
| Ballarin, J; Bover, J; DaSilva, I; Diaz-Encarnacion, MM; Fernández, E; Lloret, MJ; Mateu, S; Mercado, C; Ruiz, C; Ureña-Torres, P | 1 |
| Clark, OH; Evenepoel, P; Triponez, F; Vanrenthergem, Y | 1 |
| Block, GA; Chertow, GM; Csiky, B; Dehmel, B; Downey, G; Floege, J; Goodman, WG; Lopez, N; Moustafa, M; Naso, A; Nossuli, K; Raggi, P; Torres, PU | 1 |
| Grzegorzewska, AE | 1 |
| Almirall, J; Castañé, E; Gallardo, X | 1 |
| Karohl, C; Raggi, P | 1 |
| Floege, J; Goodman, WG; Hawley, CM; Pedagogos, E; Pétavy, F; Raggi, P; Reiner, M; Ureña-Torres, PA | 1 |
| Chudek, J; Kocełak, P; Olszanecka Glinianowicz, M; Zelaźnicka, M | 1 |
| Cooper, K; Farouk, M; Goodman, WG; Pétavy, F; Rodriguez, M; Ureña-Torres, P | 1 |
| Anders, HJ | 1 |
| Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H | 1 |
| Limardo, M; Locatelli, F; Pontoriero, G | 1 |
9 review(s) available for cinacalcet and Disease Exacerbation
| Article | Year |
|---|---|
[Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of cinacalcet on vascular calcification].
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Disease Progression; Humans; Naphthalenes; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Topics: Bone Diseases, Metabolic; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Minerals; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2016 |
Surgical treatment of persistent hyperparathyroidism after renal transplantation.
Topics: Cinacalcet; Cryopreservation; Diagnostic Imaging; Disease Progression; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Monitoring, Intraoperative; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Thymectomy | 2008 |
[Calcimimetic drugs in nondialyzed patients].
Topics: Chronic Disease; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism; Kidney Diseases; Kidney Transplantation; Naphthalenes; Parathyroid Hormone | 2010 |
Cinacalcet: will it play a role in reducing cardiovascular events?
Topics: Calcimimetic Agents; Cardiomyopathies; Cardiovascular Diseases; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Myocytes, Cardiac; Naphthalenes | 2012 |
[Cinacalcet therapy and cardiovascular risk in hemodialysis patients].
Topics: Atherosclerosis; Cardiovascular Diseases; Causality; Cinacalcet; Comorbidity; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Risk Factors; Vascular Calcification | 2012 |
[Chronic kidney disease].
Topics: Acidosis; Adult; Anemia, Aplastic; Cardiovascular Diseases; Cinacalcet; Disease Progression; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Multicenter Studies as Topic; Naphthalenes; Parathyroid Hormone; Practice Guidelines as Topic; Risk Factors | 2005 |
CKD-MBD: impact on management of kidney disease.
Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins | 2007 |
New approaches to treatment of secondary hyperparathyroidism.
Topics: Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phosphates; Receptors, Calcium-Sensing; Treatment Outcome; Vitamin D | 2008 |
4 trial(s) available for cinacalcet and Disease Exacerbation
| Article | Year |
|---|---|
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.
Topics: Aged; Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Vascular Diseases; Vitamin D | 2010 |
Effects of cinacalcet on vascular calcification in haemodialysis patients.
Topics: Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Treatment Outcome | 2010 |
Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study.
Topics: Aged; Cinacalcet; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Male; Medication Adherence; Middle Aged; Naphthalenes; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification; Vitamin D | 2013 |
Calcium-mediated parathyroid hormone suppression to assess progression of secondary hyperparathyroidism during treatment among incident dialysis patients.
Topics: Adult; Aged; Calcitriol; Cinacalcet; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Renal Dialysis; Treatment Outcome | 2013 |
4 other study(ies) available for cinacalcet and Disease Exacerbation
| Article | Year |
|---|---|
Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet.
Topics: Adenoma; Biopsy; Calcium-Regulating Hormones and Agents; Cinacalcet; Cysts; Diagnostic Errors; Disease Progression; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Thyroid Diseases; Tumor Burden; Ultrasonography | 2020 |
Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Computer Simulation; Cost-Benefit Analysis; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Medicare; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Quality-Adjusted Life Years; Renal Dialysis; Renal Elimination; Time-to-Treatment; United States | 2021 |
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Topics: Antibodies, Monoclonal, Humanized; Calcium; Cinacalcet; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune System; Immunotherapy; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Molecular Biology; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
Importance of abnormal bone metabolism in the acceleration of atherosclerosis in hemodialysis patients.
Topics: Atherosclerosis; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Disease Progression; Humans; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |